Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


Research from Indiana University School of Medicine has found that D3T – a compound that triggers copying of antioxidant genes and production of the antioxidant glutathione – delays disease...
A study investigating the safety of Tysabri in patients with early relapsing-remitting MS has been presented at the 2016 meeting of the Consortium of Multiple Sclerosis Centres (CMSC). Previous...
A study presented at the Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting in America has shown that MS patients of African descent might better benefit from treatment of Lemtrada...
A study claims newly diagnosed patients with relapsing-remitting multiple sclerosis (RRMS) showed significant improvements when treated with delayed-release dimethyl fumarate (DMF), especially in...
Community-based tai chi has been linked to improvements in endurance, strength, fatigue, and balance in a small group of patients with multiple sclerosis (MS), according a new study. Because tai chi...
Multiple sclerosis risk is lower in HIV-infected patients, according to a new study. The association apparently comes from the chronic dampening down of the immune system associated with HIV, along...
Researchers at Johns Hopkins University in Baltimore say they have found that visual function in multiple sclerosis (MS) patients correlates with cognitive function, suggesting disease severity and...
Scientists have for the first time found a gene that can be linked directly to the development of multiple sclerosis (MS). While about 10 to 15 per cent of MS cases appear to have a hereditary...
Researchers at the University of Technology Sydney (UTS) say they are planning to explore the anti-inflammatory potential of a controlled infection by parasitic worms as a way of preventing the over-...
Data from an extension phase of a Phase III clinical trial claims the biotin MD1003 showed effectiveness over time as a possible treatment of non-active, progressive multiple sclerosis (MS). The data...

Pages